Catalyst Capital Advisors’s Trueblue TBI Stock Holding History

Catalyst Capital Advisors’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,500	Closed	-$469K	–	322
2019 Q4	$469K	Buy	+19,500	New	+$445K	0.02%	177

Other funds holding TBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Catalyst Capital Advisors's TBI Position: Q1 2020 in Review

Catalyst Capital Advisors sold out of Trueblue (TBI) in Q1 2020, closing a stake of 19,500 shares — an estimated $469K sold.

Catalyst Capital Advisors first reported a position in TBI in Q4 2019 and held it in 1 quarter. The position peaked at $469K in Q4 2019. 157 funds tracked by Wall St. Rank hold TBI as of Q1 2020.

Catalyst Capital Advisors reported no remaining Trueblue position as of Q1 2020 after selling out during the quarter.
Catalyst Capital Advisors sold 19,500 Trueblue shares in Q1 2020, an estimated $469K.
Catalyst Capital Advisors first reported a position in Trueblue in Q4 2019 and held it in 1 quarter.
Catalyst Capital Advisors's Trueblue position peaked at $469K in Q4 2019.
157 funds tracked by Wall St. Rank held Trueblue as of Q1 2020.

Based on Catalyst Capital Advisors's 13F filing for Q1 2020, filed 12 May 2020.